Artemisinins
Showing 1 - 25 of 66
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Vulvar Diseases, HPV Infection, Vulvar HSIL Trial in Cleveland, Mayfield Heights (Artesunate ointment, Placebo ointment)
Not yet recruiting
- Vulvar Diseases
- +12 more
- Artesunate ointment
- Placebo ointment
-
Cleveland, Ohio
- +2 more
Oct 4, 2023
Plasmodium Falciparum Antimalarial Drug Resistance Markers
Completed
- Plasmodium Falciparum
-
Kome, Doba, ChadStudy clinic
Mar 29, 2022
Hepatocellular Carcinoma Trial in Ghent (Artesunate)
Terminated
- Hepatocellular Carcinoma
-
Ghent, East-Flandres, BelgiumDept. of Hepatology & Gastroenterology Ghent University Hospital
Oct 19, 2021
Covid 19 Positive, Corona Virus Infection Trial in Riyadh (Artemisinin / Artesunate, )
Withdrawn
- Covid 19 Positive
- Corona Virus Infection
- Artemisinin / Artesunate
- placebo
-
Riyadh, Central, Saudi ArabiaPrincess Nourah Bint Abdulrahman Univeristy
Apr 26, 2022
Malaria, Falciparum Trial in Cambodia, Vietnam (ACT, TACT)
Completed
- Malaria, Falciparum
-
Siem Pang, Stung Treng, Cambodia
- +3 more
Mar 17, 2022
Plasmodium Vivax Trial in Vientiane (Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ), Dihydroartemisinin-piperaquine (DP)
Completed
- Plasmodium Vivax
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ)
- Dihydroartemisinin-piperaquine (DP) + Primaquine (PQ) placebo
-
Vientiane, Lao People's Democratic RepublicLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit
Feb 14, 2022
Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York
Not yet recruiting
- Anal High Grade Squamous Intraepithelial Lesion
- +5 more
- Artesunate
- Placebo
-
San Francisco, California
- +2 more
Nov 7, 2022
Colorectal Cancer, Bowel Cancer Trial in United Kingdom (Artesunate 200mg, Placebo)
Active, not recruiting
- Colorectal Cancer
- Bowel Cancer
- Artesunate 200mg
- Placebo
-
Gillingham, Kent, United Kingdom
- +5 more
Oct 5, 2021
HPV-Related Anal Intraepithelial Neoplasia, AIN2/3, Artesunate Trial in Baltimore, Madison (Artesunate Suppositories)
Completed
- HPV-Related Anal Intraepithelial Neoplasia
- +6 more
- Artesunate Suppositories
-
Baltimore, Maryland
- +1 more
Nov 2, 2021
Uncomplicated Plasmodium Falciparum Malaria Trial in Busia, Tororo (Artemether-lumefantrine)
Completed
- Uncomplicated Plasmodium Falciparum Malaria
-
Busia, Uganda
- +1 more
Oct 20, 2022
Malaria Trial (Artemether-Lumefantrine Drug Combination, Dihydroartemisinin-Piperaquine drug combination)
Not yet recruiting
- Malaria
- Artemether-Lumefantrine Drug Combination
- Dihydroartemisinin-Piperaquine drug combination
- (no location specified)
Apr 15, 2022
Plasmodium Falciparum Trial in Kilifi (Arterolane-piperaquine, Arterolane-piperaquine+mefloquine, Artemether-lumefantrine)
Completed
- Plasmodium Falciparum
- Arterolane-piperaquine
- +2 more
-
Kilifi, KenyaKilifi County Hospital
Sep 28, 2021
Malaria, Febrile Illness Trial in Lagos (Testing incentive, Conditional artemisinin combination therapy subsidy)
Recruiting
- Malaria
- Febrile Illness
- Testing incentive
- Conditional artemisinin combination therapy subsidy
-
Lagos, NigeriaClinton Health Access Initiative
Feb 4, 2022
Plasmodium Falciparum Malaria (Uncomplicated) Trial in Bangladesh, Cambodia, Indonesia (Artemether-lumefantrine+amodiaquine,
Recruiting
- Plasmodium Falciparum Malaria (Uncomplicated)
-
Cox's Bāzār, Chittagong, Bangladesh
- +3 more
Jan 31, 2022
COVID-19 Trial in Jardim (OT-101, Artemisinin, Placebo)
Unknown status
- COVID-19
- OT-101
- +2 more
-
Jardim, BrazilPraxis Pesquisa Medica S / S Ltda
Mar 15, 2021
Recurrent Respiratory Papillomatosis, Human Papilloma Virus Trial in United Kingdom (Microdebrider, Cold-steel surgery
Recruiting
- Recurrent Respiratory Papillomatosis
- Human Papilloma Virus
- Microdebrider
- +9 more
-
Aberdeen, United Kingdom
- +47 more
Jan 10, 2022
Falciparum Malaria Trial (Artesunate-amodiaquine drug combination, Artemether-lumefantrine drug combination)
Not yet recruiting
- Falciparum Malaria
- Artesunate-amodiaquine drug combination
- Artemether-lumefantrine drug combination
- (no location specified)
Mar 31, 2021
Malaria,Falciparum Trial in Yaoundé (Artesunate-amodiaquine combination, Artemether, Lumefantrine Drug Combination)
Completed
- Malaria,Falciparum
- Artesunate-amodiaquine combination
- Artemether, Lumefantrine Drug Combination
-
Yaoundé, Center, CameroonDistrict Medical Center Minkoa Meyos
Mar 31, 2021
Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth Trial in Kinshasa, Eldoret (Malaria High-Sensitivity Rapid
Not yet recruiting
- Malaria,Falciparum
- +8 more
- Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
-
Kinshasa, Congo, The Democratic Republic of the
- +1 more
Feb 24, 2023
Malaria Trial in Bissau (Artemether-lumefantrine, Dihydroartemisinin-piperaquine)
Completed
- Malaria
-
Bissau, Guinea-BissauBandim Health Project
May 25, 2021
Covid19, Diabetes, Hypertension Trial in Mexico City (Camostat Mesilate, Artemisia Annua Leaf)
Terminated
- Covid19
- +3 more
- Camostat Mesilate
- Artemisia Annua Leaf
-
Mexico City, None - Non-US/Canada, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jun 15, 2021
Crohn's Disease Trial in Lucknow (Artesunate, Curcumin, Placebo A)
Not yet recruiting
- Crohn's Disease
- Artesunate
- +3 more
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIM
Jan 20, 2021